[Federal Register Volume 62, Number 26 (Friday, February 7, 1997)]
[Notices]
[Page 5835]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-3018]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of Commission on Dietary Supplement Labels
AGENCY: Office of Disease Prevention and Health Promotion.
ACTION: Commission on Dietary Supplement Labels: Notice of meeting #8.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) is providing
notice of the eighth meeting of the Commission on Dietary Supplement
Labels.
DATES: The Commission intends to hold its meetings on March 4, 1997
from 1:00 p.m. to approximately 5:00 p.m., E.S.T., at the Omni Hotel,
101 West Fayette Street, Baltimore, Maryland 21201. The meeting is open
to the public; seating is limited.
FOR FURTHER INFORMATION CONTACT: Kenneth D. Fisher, Ph.D., Executive
Director, Commission on Dietary Supplement Labels, Office of Disease
Prevention and Health Promotion, Room 738G, Hubert H. Humphrey
Building, 200 Independence Ave., SW., Washington, DC 20201, (202) 690-
7102.
SUPPLEMENTARY INFORMATION: Public Law 103-417, Section 12, authorized
the establishment of a Commission on Dietary Supplement Labels whose
seven members have been appointed by the President. The appointments to
the Commission by the President and the establishment of the Commission
by the Secretary of Health and Human Services reflect the commitment of
the President and the Secretary to the development of a sound and
consistent regulatory policy on labeling of dietary supplements.
The Commission is charged with conducting a study and providing
recommendations for regulation of label claims and statements for
dietary supplements, including the use of supplemental literature in
connection with their sale and, in addition, procedures for evaluation
of label claims. The Commission is expected to evaluate how best to
provide truthful, scientifically valid, and non-misleading information
to consumers in order that they may make informed health care choices
for themselves and their families. The Commission's study report may
include recommendations on legislation, if appropriate and necessary.
The Commission meeting agenda will include approval of minutes of
the previous meeting, determination of the appropriateness and possible
date for release of the Commission's final draft report for public
review, review of certain materials drafted for possible inclusion in
the Commission's report, and discussion of the process for review of
Commission's final draft report. In addition, the Commission has
requested further comments from several organizations that previously
provided testimony and statements concerning (1) regulatory management
of herbal remedies, and (2) possible use of third parties for
evaluation of dietary supplement label claims. Oral statements and the
required written statements of invited parties are to be restricted to
additional views, data, and comments on these two topics. If time
permits after the statements of the invited organizations, the Chair
may allow brief oral statements from other interested parties and
persons concerning these two topics.
The meeting is open to the public; however seating is limited. If
you will require a sign language interpreter, please call Sandra
Saunders (202) 690-7102 by 4:30 p.m. E.S.T. on February 24, 1997.
Dated: January 30, 1997.
Linda D. Meyers,
Acting Deputy Director, Office of Disease Prevention and Health
Promotion, Department of Health and Human Services.
[FR Doc. 97-3018 Filed 2-6-97; 8:45 am]
BILLING CODE 4160-17-M
